Ernst & Young has recently conducted a survey of 40 senior managers of 15 leading pharmaceutical companies operating in China. The survey results show that due to the expansion of China's health care plan and the growth of population affluence, the demand for drugs is increasing. In the next few years, China will become one of the most important growth markets.
Although most of the interviewed companies have accelerated their penetration into the Chinese market, they have adopted very different business models. Some companies have increased their investment in R&D in China, some have expanded their sales and marketing operations in China, and still others have passed. Build partnerships with local companies to sell products in China. Although the impact of China's health care reforms is not yet clear, intense competition has enabled multinational pharmaceutical companies to quickly identify the right strategies to address the major challenges facing China's business.
Mr. Li Yongguang, partner in the pharmaceutical industry in Anchangdong District, said that “the expansion of the global pharmaceutical company is showing that China’s growing purchasing power and broader medical system have brought important development opportunities.
Cooler And Warmer Box,Warmer Box,Cooler Box ,Electric Cool Box
Yuyao Veedai Electrical Appliance Co., Ltd , https://www.nbkxveed.com